Herein, we aimed to investigate the possible prognostic potential of IL-37 in patients with BLCA using a series of bioinformatics tools and publicly available databases, followed by validation using specifically developed qPCR assays. The gene discussed is IL37; the disease is bladder transitional cell carcinoma.